HIV-related wasting in HIV-infected drug users in the era of highly active antiretroviral therapy

Clinical Infectious Diseases

Volumn 41, Issue 8, 2005, Pages 1179-1185

  Campa, Adrians ^a   Yang, Zhifang ^a   Lai, Shenghan ^c   Xue, Lihua ^b   Phillips, J Craig ^a   Sales, Sabrina ^a   Page, J Bryan ^b   Baum, Marianna K ^a  

^a FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTIRETROVIRUS AGENT; CANNABIS; COCAINE; DIAMORPHINE; VIRUS RNA;

ADULT; ALCOHOL ABUSE; ANAMNESIS; ARTICLE; BLOOD SAMPLING; BODY MASS; CONFIDENCE INTERVAL; DEMOGRAPHY; DRUG ABUSE; FEEDING BEHAVIOR; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; UNITED STATES; VIRUS LOAD; WASTING SYNDROME;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COHORT STUDIES; DIET; FEMALE; FLORIDA; HIV WASTING SYNDROME; HOMELESS PERSONS; HUMANS; MALE; ODDS RATIO; PREVALENCE; QUALITY OF LIFE; RISK FACTORS; RNA, VIRAL; SOCIOECONOMIC FACTORS; SUBSTANCE-RELATED DISORDERS; VIRAL LOAD;

EID: 26444594914     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/444499     Document Type: Article

References (52)

1. Simply stated...are people still wasting? Res Initiat Treat Action 1998;4:15.
2. Roubenoff R, Grinspoon S, Skolnik PR, et al. Role of cytokines and testosterone in regulating lean body mass and resting energy expenditure in HIV-infected men. Am J Physiol Endocrinol Metab 2002; 283:E138-45.
3. Reiter GS. The HIV wasting syndrome. AIDS Clin Care 1996; 8:89-91, 93, 96.
4. Kotler DP. Nutritional alterations associated with HIV infection. J Acquir Immune Defic Syndr 2000; 25(Suppl 1):S81-7.
5. Wheeler DA, Gibert CL, Launer CA, et al. Weight loss as a predictor of survival and disease progression in HIV infection: Terry Beirn Community Programs for Clinical Research on AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 18:80-5.
6. Tang AM, Forrester J, Spiegelman D, Knox TA, Tchetgen E, Gorbach SL. Weight loss and survival in HIV-positive patients in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2002; 31:230-6.
7. Palenicek IP, Graham NM, He YD, et al. Weight loss prior to clinical AIDS as a predictor of survival. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 10:366-72.
8. Yang Z, Campa A, Philips JC, et al. Wasting in the era of HAART-is hunger the primary concern [abstract TuPeD5277]? In: Access for all: abstract book. XV International HIV/AIDS Conference (Bangkok, Thailand). Bangkok: International AIDS Society, 2004:517.
9. Wanke CA, Silva M, Knox TA, Forrester J, Speigelman D, Gorbach SL. Weight loss and wasting remain common complications in individuals infected with human immunodeficiency virus in the era of highly active antiretroviral therapy. Clin Infect Dis 2000; 31:803-5.
10. Hodgson LM, Ghattas H, Pritchitt H, Schwenk A, Payne L, Macallant DC. Wasting and obesity in HIV outpatients. AIDS 2001; 15:2341-2.
11. Gayle H. An overview of the global HIV/AIDS epidemic with a focus in the United Sates. AIDS 2000; 14(Suppl 2):S8-17.
12. Khalsa JH, Genser S, Coates P, Francis H. Interventions for metabolic and endocrine complications of human immunodeficiency virus/acquired immune deficiency syndrome and illicit drug use. Clin Infect Dis 2003;37(Suppl 2):S37-42.
13. Wanke CA, Silya M, Ganda A, et al. Role of acquired immune deficiency syndrome-defining conditions in human immunodeficiency virus-associated wasting. Clin Infect Dis 2003; 37(Suppl 2):S81-4.
14. Tansuphasawadikul S, Amornkul PN, Tanchanpong C, et al. Clinical presentation of hospitalized adult patients with HIV infection and AIDS in Bangkok, Thailand. J Acquir Immune Defic Syndr 1999; 21:326-32.
15. Batterham MJ, Garsia R, Greenop P. Prevalence and predictors of HIV-associated weight loss in the era of highly active antiretroviral therapy. Int J STD AIDS 2002; 13:744-7.
16. Mwamburi DM, Wilson IB, Jacobson DL, et al. Understanding the role of HIV load in determining weight change in the era of highly active antiretroviral therapy. Clin Infect Dis 2005; 40:167-73.
17. Lyles RH, Tang AM, Smit E, et al. Virologic, immunologic, and immune activation markers as predictors of HIV-associated weight loss prior to AIDS: Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr 1999; 22:386-94.
18. Visnegarwala F, Graviss EA, Sajja P, Lahart CJ, White AC. Determinants of sustained virological suppression in indigent, HIV-infected patients: is single protease inhibitor-based antiretroviral therapy truly highly active? HIV Clin Trials 2004; 5:117-24.
19. Kuritzkes DR. Preventing and managing antiretroviral drug resistance. AIDS Patient Care STDS 2004; 18:259-73.
20. McNabb J, Ross JW, Abriola K, Turley C, Nightingale CH, Nicolau DP. Adherence to highly active antiretroviral therapy predicts virologic outcome at an inner-city human immunodeficiency virus clinic. Clin Infect Dis 2001;33:700-5.
21. Shapiro MF, Morton SC, McCaffrey DF, et al. Variations in the care of HIV-infected adults in the United States. JAMA 1999; 281:2305-15.
22. Celentano DD, Vlahov D, Cohn S, Shadle VM, Obasanjo O, Moore RD. Self-reported antiretroviral therapy in injection drug users. JAMA 1998; 280:544-6.
23. Trowbridge FL, Wong FL. Surveillance of severe pediatric undernutrition: conceptual and practical issues. J Nutr 1990; 120:943-7.
24. Fleming PL, Ciesielski CA, Byers RH, Castro KG, Berkelman RL. Gender differences in reported AIDS-indicative diagnoses. J Infect Dis 1993; 168:61-7.
25. Abrams DI. Potential interventions for HIV/AIDS wasting: an overview. J Acquir Immune Defic Syndr 2000;25(Suppl 1):S74-80.
26. Süttmann U, Ockenga J, Selberg O, Hoogestraat L, Deicher H, Müller MJ. Incidence and prognostic value of malnutrition and wasting in human immunodeficiency virus-infected outpatients. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 8:239-46.
27. Chan IS, Neaton JD, Saravolatz LD, Crane LR, Osterberger J. Frequencies of opportunistic diseases prior to death among HIV infected persons. AIDS 1995; 9:1145.
28. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection: HIV Outpatient Study Investigators. N Engl J Med 1998; 338:853-60.
29. Hogg RS, Heath KV, Yip B, et al. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA 1998; 279:450-4.
30. McNaghten AD, Hanson DL, Jones IL, Dworkin MS, Ward IW. Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis. AIDS 1999; 13:1687-95.
31. Marmor M, Titus S, Harrison C, et al. Weight loss associated with HIV seroconversion among injection-drug users. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 12:514-8.
32. Yeni PG, Hammer SM, Hirsch MS, et al. Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel. JAMA 2004; 292:266-8.
33. Williams PB. HIV/AIDS case profile of African Americans: guidelines for ethnic-specific health promotion, education, and risk reduction activities for African Americans. Fam Community Health 2003; 26:289-306.
34. Morales LS, Cunningham WE, Galvan FH, Andersen RM, Nakazono TT, Shapiro MF. Sociodemographic differences in access to care among Hispanic patients who are HIV infected in the United States. Am J Public Health 2004; 94:1119-21.
35. Stone VE. Optimizing the care of minority patients with HIV/AIDS. Clin Infect Dis 2004; 38:400-4.
36. Johnson DF, Sorvillo FJ, Wohl AR, et al. Frequent failed early HIV detection in a high prevalence area: implications for prevention. AIDS Patient Care STDS 2003; 17:277-82.
37. Kalichman SC, Catz S, Ramachandran B. Barriers to HIV/AIDS treatment and treatment adherence among African-American adults with disadvantaged education. J Natl Med Assoc 1999; 91:439-46.
38. Lee-Ougo W, Boekeloo BO, Thompson EE, et al. Provider perceptions of key barriers to providing state-of-the-art clinical care for HIV-infected African-American patients. J Natl Med Assoc 2003;95(Suppl 2):S12-20.
39. Rivera S, Briggs W, Oian D, Sattler FR. Levels of HIV RNA are quantitatively related to prior weight loss in HIV-associated wasting. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 17:411.
40. Zangerle R, Sarcletti M, Gallati H, Reibnegger G, Wachter H, Fuchs D. Decreased plasma concentrations of HDL cholesterol in HIV-infected individuals are associated with immune activation. J Acquir Immune Defic Syndr 1994; 7:1149-56.
41. Constans J, Pellegrin JL, Peuchant F, et al. Plasmalipids in HIV-infected patients: a prospective study in 95 patients. Eur J Clin Invest 1994; 24:416-20.
42. Riddler SA, Smit E, Cole SR, et al. Impact of HIV infection and HAART on serum lipids in men. JAMA 2003; 289:2978-82.
43. Levine JA, Harris MM, Morgan MY. Energy expenditure in chronic alcohol abuse. Eur J Clin Invest 2000; 30:749-50.
44. Pacy PJ, Preedy VR, Peters TJ, Read M, Halliday D. The effect of chronic alcohol ingestion on whole body and muscle protein synthesis-a stable isotope study. Alcohol Alcohol 1991;26:505-13.
45. Wiederman MW, Pryor T. Substance use among women with eating disorders. Int J Eat Disord 1996; 20:163-8.
46. Jonas JM, Gold MS, Sweeney D, Pottash AL. Eating disorders and cocaine abuse: a survey of 259 cocaine abusers. J Clin Psychiatry 1987; 48:47-50.
47. Smit E, Skolasky RL, Dobs AS, et al. Changes in the incidence and predictors of wasting syndrome related to human immunodeficiency virus infection, 1987-1999. Am J Epidemiol 2002; 156:211-8.
48. Wagner GJ, Ferrando SJ, Rabkin JG. Psychological and physical health correlates of body cell mass depletion among HIV+ men. J Psychosom Res 2000; 49:55-7.
49. Singh N, Squier C, Sivek C, Wagener M, Nguyen MH, Yu VL. Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance. AIDS Care 1996; 8:261-9.
50. Beaugerie L, Carbonnel F, Carrat F, et al. Factors of weight loss in patients with HIV and chronic diarrhea. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 19:34-9.
51. Kim JH, Spiegelman D, Rimm F, Gorbach SL. The correlates of dietary intake among HIV positive adults. Am J Clin Nutr 2001; 74:852-61.
52. Woods MN, Spiegelman D, Knox TA, et al. Nutrient intake and body weight in a large HIV cohort that includes women and minorities. J Am Diet Assoc 2002; 102:203-11.